-
Viewpoint: TPP’s Outcome Pivotal for Future of Global Biomedical Innovation
After seven years of wrangling toward the final terms of an ambitious free trade agreement that will join 12 Asia-Pacific nations, only the thorniest of market access and intellectual property issues remain unresolved in the Trans-Pacific Partnership (TPP). Of these, perhaps the most contentious concerns how long pharmaceutical companies should have exclusive intellectual property rights covering the clinical trial data they compile as they develop novel biologic medicines. U.S. negotiators have stood fast in advocating for 12 years of data protection — the standard that Congress enshrined into U.S. law following extensive deliberation — while other TPP parties have sought to limit the regulatory data protection period to as little as five to seven years.
- Categories
- Health Care
- Tags
- public policy
-
Health Solutions for Rural India
How do you design a developmental solution or provide a digital tool for a poor and inaccessible area where visitors are tracked by Maoists? An area so remote that barely any telecom network works, where more than 90% of the population lives in villages.
- Categories
- Health Care
-
Weekly Roundup – 8/15/15: Coke goes fact-free in a week of missteps by multinational organizations
It's not easy being big. Especially when NextBillion's editors are on the lookout for Roundup fodder. This week we sharpened our elbows to take on Coke, the United Nations, Google ... and even the Catholic church. Let us know if you agree with our opinions; we'd love to run some counterpoints in an upcoming Roundup.
- Categories
- Health Care, Technology
- Tags
- public health
-
Why drug companies are betting big on ‘pharmerging’ countries
Developing countries like China, Brazil and India will drive nearly half of the growth in drug spending in the near future. Here’s how Big Pharma could play the trend.
- Categories
- Health Care
-
Can randomized trials eliminate global poverty?
A new generation of economists is trying to transform global development policy through the power of randomized controlled trials.
- Categories
- Health Care
-
Bill Gates to Narendra Modi: You Need to Generate New Healthcare Models for India
After over a year in power, the Narendra Modi government's decisions to cut federal welfare spending on the poorest of India's 1.25 billion people have come in for a sharp criticism, including from within his cabinet.
- Categories
- Health Care
- Region
- South Asia
-
GE Commits $14.7 Million to Build Healthcare Skills in East Africa
The global health sector, particularly in the developing countries, faces critical workforce shortages. Africa ranks the lowest in the availability of health personnel. Sub-Saharan Africa is home to 12 percent of the world’s population and bears 25 percent of the world’s burden of diseases, but has only three percent of the world’s health workforce.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- impact investing
-
Bid protest denied on largest-ever USAID award
The Government Accountability Office has denied a bid protest filed in response to the U.S. Agency for International Development’s award decision on the Global Health Supply Chain – Procurement and Supply Management project, the agency’s largest-ever contract, valued at $9.5 billion.
- Categories
- Health Care
- Tags
- supply chains
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.